New hope for preventing preterm births: IL-6R blockade reduces neonatal mortality

The role of interleukin (IL)-6 and IL-1α in sterile intraamniotic inflammation (SIAI), a condition associated with preterm birth (PTB).

Medtronic claims win in Axonics patent row, pushes for jury trial

Dive Brief: The U.S. Patent Trial and Appeal Board (PTAB) upheld two Medtronic patents challenged by Axonics in written decisions published Thursday. Axonics tried to show

March 22, 2024

UK diet survey study investigates inclusion of ultra-processed foods in dietary guidelines

Whether processed foods follow all dietary recommendations.

February 16, 2024

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 08.10.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.